Literature DB >> 33108663

Metabolomics Analysis of Viral Therapeutics.

Haiwei Gu1, Xiaojian Shi2, Paniz Jasbi2, Jeffrey Patterson2.   

Abstract

Virotherapy, enabled by recent advances in the transdisciplinary field of biotechnology, has emerged as a powerful tool for use in anticancer treatment, gene therapy, immunotherapy, etc. Examining the effects of viruses and virus-derived immune-modulating therapeutics is of great fundamental and clinical interest. Here we describe a sample preparation protocol for metabolite extraction from virus-infected tissue, in addition to liquid chromatography-mass spectrometry conditions essential for subsequent analysis. This metabolomics approach delivers highly sensitive and specific metabolite information on various biospecimens. Such an approach may be adopted to monitor biological changes in over 30 relevant metabolic pathways in response to viral infection and also viral therapeutics.

Entities:  

Keywords:  LC-MS/MS; Metabolomics; Sample preparation; Viral vector; Virotherapy

Mesh:

Year:  2021        PMID: 33108663      PMCID: PMC9306275          DOI: 10.1007/978-1-0716-1012-1_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  39 in total

Review 1.  Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials.

Authors:  Jason R Clark; John B March
Journal:  Trends Biotechnol       Date:  2006-03-29       Impact factor: 19.536

2.  Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis.

Authors:  Patrick A Carroll; Daniel Diolaiti; Lisa McFerrin; Haiwei Gu; Danijel Djukovic; Jianhai Du; Pei Feng Cheng; Sarah Anderson; Michelle Ulrich; James B Hurley; Daniel Raftery; Donald E Ayer; Robert N Eisenman
Journal:  Cancer Cell       Date:  2015-01-29       Impact factor: 31.743

3.  Breast cancer detection using targeted plasma metabolomics.

Authors:  Paniz Jasbi; Dongfang Wang; Sunny Lihua Cheng; Qiang Fei; Julia Yue Cui; Li Liu; Yiping Wei; Daniel Raftery; Haiwei Gu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2018-12-03       Impact factor: 3.205

4.  Metabolomics Toward Biomarker Discovery.

Authors:  Peiyuan Yin; Guowang Xu
Journal:  Methods Mol Biol       Date:  2017

Review 5.  A Unified Conceptual Framework for Metabolic Phenotyping in Diagnosis and Prognosis.

Authors:  Jeremy R Everett; Elaine Holmes; Kirill A Veselkov; John C Lindon; Jeremy K Nicholson
Journal:  Trends Pharmacol Sci       Date:  2019-09-09       Impact factor: 14.819

6.  Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.

Authors:  George A Kaysen; Kirsten L Johansen; Glenn M Chertow; Lorien S Dalrymple; John Kornak; Barbara Grimes; Tjien Dwyer; Alexander W Chassy; Oliver Fiehn
Journal:  J Ren Nutr       Date:  2015-03-19       Impact factor: 3.655

7.  Biomarker Discovery and Translation in Metabolomics.

Authors:  G A Nagana Gowda; D Raftery
Journal:  Curr Metabolomics       Date:  2013

8.  Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS.

Authors:  Jeremiah Bowers; Emma Hughes; Nicholas Skill; Mary Maluccio; Daniel Raftery
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-03-02       Impact factor: 3.205

Review 9.  The Gastrointestinal Microbiome: A Review.

Authors:  P C Barko; M A McMichael; K S Swanson; D A Williams
Journal:  J Vet Intern Med       Date:  2017-11-24       Impact factor: 3.333

10.  Metabolic profiling of hepatitis B virus-related hepatocellular carcinoma with diverse differentiation grades.

Authors:  Lei Zhang; Ya Huang; Mingjian Lian; Zhijuan Fan; Yaqiong Tian; Yufan Wang; Hua Kang; Shuang Liu; Shuye Liu; Tong Li; Zhongqiang Shan
Journal:  Oncol Lett       Date:  2017-01-11       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.